MKI67 and neuroendocrine neoplasm: The median Ki67 index of MAP tumors ranged from 7.2 to 14.8% (mean 10.9%) at the 8-month time point (Fig. 2F), which is consistent with intermediate grade 2 (G2) neuroendocrine tumors (Ki67 index of 3–20%).